Home About us Contact | |||
Verbal Recall (verbal + recall)
Selected AbstractsThe neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differACTA PSYCHIATRICA SCANDINAVICA, Issue 6 2009U. Goswami Objective:, Although it is established that euthymic bipolar patients have neurocognitive deficits, the influence of medication on their cognitive performance is uncertain and requires investigation. Method:, Neuropsychological tests of executive function, memory and attention were performed on 44 prospectively verified, euthymic bipolar I patients, 22 of whom were drug-free. Residual mood symptom effects were controlled statistically using ancova. Results:, Drug-free and medicated patients differed only in delayed verbal recall (Rey AVLT list A7, drug-free > medicated), and perseverations during the five-point test (drug-free > medicated). When residual mood symptoms were controlled statistically, differences between drug-free and medicated subjects became insignificant. Medication effect sizes were modest. Significant correlations were found between residual depression scores and measures of verbal learning. Conclusion:, Medications did not have any significant influence on neurocognitive performance, suggesting that neurocognitive deficits are an integral part of bipolar disorder. [source] A 2-year-old child's memory of hospitalization during early infancyINFANT AND CHILD DEVELOPMENT, Issue 6 2008Aletha Solter Abstract A child who had had surgery at 5 months of age, and who had been treated at the time for post-traumatic symptoms (reported in a previous paper by the author), was interviewed 2 years later and almost 3 years later to test for possible verbal recall of his hospitalization. He appeared to have some memories of the experience at 29 months of age, and he was able to superimpose verbal labels onto the preverbal memories. At 40 months of age, however, the memories were no longer verbally accessible. The results are discussed in the context of different theories of encoding, storage, retrieval, and loss of early memories. The findings from this study support other findings indicating that there appears to be some form of long-term memory in place early in life, at least for highly salient, traumatic events. There may be one memory system for traumatic memories, fully functional at birth, and a later developing, different system for neutral memories. It is further hypothesized that there may be a sensitive period around 2,3 years of age for the recall of early traumatic memories, and that verbal recall is more likely to be present in verbally precocious children during that period. Copyright © 2008 John Wiley & Sons, Ltd. [source] Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performanceINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Issue 10 2003Jacques Allard Abstract Background There have been few general population studies of the effects of psychotropic treatment on cognitive functioning in the elderly. Current evidence based on studies with numerous procedural shortenings supports the notion of the detrimental effect. Objectives To examine changes in a wide range of specific cognitive abilities across time in a general population sample in order to establish a relationship between psychotropic drug use and cognitive performance, and to estimate to what extent such cognitive changes may be attributable to psychotropic use or other factors, notably age and co-morbidity. Method We analysed the data from the Eugeria longitudinal study of cerebral ageing. Three hundred and seventy two subjects (263 female and 109 male) were visited at their place of residence and given a computerized cognitive examination. Depressive symptomatology and depressive episodes were defined according to ICD-9 criterias and medication use were established. Four categories of psychotropic consumers was differentiated. Using a logistic regression model, comparisons were made between consumers and non-consumers. Results A significant positive effect in chronic consumers was found on tests of secondary memory (delayed verbal recall: Odds Ratio (OR),=,1.22; 95% Confidence Intervals (CI) [1.04,1.43]; p,=,0.013) and this effect is principally attributable to antidepressants with significant effects being shown for both verbal (OR,=,1.59; 95%CI [1.18,2.14]; p,=,0.002) and visual recall (OR,=,1.51; 95%CI [1.05,2.16]; p,=,0.025). No effect is found for benzodiazepines. Conclusions Contrary to the common belief that psychotropic drug use has a detrimental effect on cognitive function of elderly people, even long term use is seen to be benign. We attest to the positive effects of antidepressant therapy on secondary memory. Copyright © 2003 John Wiley & Sons, Ltd. [source] Frontotemporal dementia: patient characteristics, cognition, and behaviourINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Issue 10 2002J. Diehl Abstract Objectives To describe sociodemographic data of patients with frontotemporal dementia (FTD), to compare the cognitive profile of patients with FTD with that of severity-matched patients with Alzheimer's disease using the CERAD neuropsychological battery (CERAD-NP), to investigate the frequency of behavioural disturbances, and to examine the relation between FTD-specific non-cognitive behavioural symptoms of patients with FTD with age and sex. Methods Fifty outpatients were diagnosed with FTD according to the Lund-Manchester consensus criteria. Cognitive impairment was assessed in 30 patients using the CERAD-NP. Severity of dementia was rated on the Clinical Dementia Rating (CDR). Eleven non-cognitive symptoms were rated by severity. To compare CERAD-NP results between patients with FTD and AD, 30 patients with AD were matched for age, sex, and global severity of cognitive performance. Results The average age at onset of first symptoms was 57.8 years. Eighteen patients (36%) had a positive family history of dementia. On the CERAD-NP patients with FTD performed significantly better than patients with AD on word list learning, delayed verbal recall and visuoconstruction (p<0.05). There were no significant differences between FTD and AD on naming and verbal fluency tasks. The most frequent non-cognitive behavioural symptoms in FTD were loss of insight, speech abnormality, and apathy. Non-cognitive behavioural symptoms were more frequent in younger and in male than in older patients and in female patients. Conclusions The CERAD-NP is a valuable clinical instrument for the cognitive evaluation of patients with suspected FTD. Complementary short tests of attention and executive function may be recommended. To enhance diagnostic sensitivity informant interviews should focus on non-cognitive behavioural changes, taking advantage of standardised questionnaires. Copyright © 2002 John Wiley & Sons, Ltd. [source] Anemia and 9-Year Domain-Specific Cognitive Decline in Community-Dwelling Older Women: The Women's Health and Aging Study IIJOURNAL OF AMERICAN GERIATRICS SOCIETY, Issue 9 2009Jennifer A. Deal MHS OBJECTIVES: To test the hypothesis that anemia (hemoglobin <12 g/dL) is associated with a faster rate of cognitive decline over 9 years in a community-dwelling sample of women aged 70 to 80 at baseline. DESIGN: A population-based, prospective cohort study. SETTING: East Baltimore, Maryland. PARTICIPANTS: Four hundred thirty-six women sampled to be representative of the two-thirds least-disabled women aged 70 to 80 at baseline (1994,1996). MEASUREMENTS: Nine-year trajectories of cognitive decline, analyzed using linear random effects models, in the domains of immediate verbal recall, delayed verbal recall, psychomotor speed, and executive function. RESULTS: At baseline and after adjustment for demographic and disease covariates, women with anemia were slower to complete a test of executive function; the difference in baseline function between women with anemia and those without was ,0.43 standard deviations (SDs) (95% confidence interval (CI)=,0.74 to ,0.13) on the Trail Making Test Part B. During follow-up, anemia was associated with a faster rate of decline in memory. Between baseline and Year 3, the difference in the rates of decline between women with anemia and those without was ,0.18 SDs per year (95% CI=,0.29 to ,0.06) on the Hopkins Verbal Learning Test (HVLT) and ,0.15 SDs per year (95% CI=,0.26 to ,0.04) on the HVLT-Delayed. CONCLUSION: Anemia was associated with poorer baseline performance on a test of executive function and with faster rates of decline on tests of immediate and delayed verbal recall. If this relationship is causal, it is possible that treatment of anemia could prevent or postpone cognitive decline. [source] Interrogative Suggestibility among Witnesses with Mild Intellectual Disabilities: the Use of an Adaptation of the GSSJOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, Issue 1 2002Rebecca Milne Background As part of the assessment of witnesses' ability to provide an account to the police and the courts, information is sometimes sought concerning their level of interrogative suggestibility. The most widely used measure for this is the Gudjonsson Suggestibility Scale (GSS, Gudjonsson 1997), which has two parallel forms (GSS 1 and GSS 2). However, the GSS relates to a verbally presented narrative, not to a visual event, as is more common to witness situations. Methods The present study adapted the scale's format so that the questions referred to a video-taped incident that had been viewed 24 h earlier by men and women with mild intellectual disabilities (n = 47) and their ,general population' counterparts (n = 38). Results The pattern of results was identical to that typically obtained using the GSS in that: (1) compared with their general population counterparts, the participants with intellectual disabilities were more suggestible because of their vulnerability to the ,misleading questions'; (2) suggestibility scores correlated with the participants' verbal recall of the incident, and (3) both participants with intellectual disabilities and their general population counterparts who were misled by questions in the form of two false alternatives were more likely to select the latter option. Conclusions The implications of these findings for psychological assessments of potential witnesses are discussed. [source] Delayed neuropsychologic dysfunction after liver transplantation for acute liver failure: A matched, case-controlled studyLIVER TRANSPLANTATION, Issue 10 2002Elizabeth W. Jackson Although several studies have identified posttransplant neurologic sequelae in patients with acute liver failure (ALF), the effects of these sequelae on neuropsychologic functioning after transplant is unknown. This study compared neuropsychologic functioning of ALF patients with chronic liver disease patients after liver transplantation. After liver transplantation, seven ALF patients were compared with a matched control group of patients who had been transplanted for chronic liver disease. The patients were matched by gender, age (within 5 years), and time since transplantation (within 2 years). Patients completed a 2-hour battery of tests, which included measures of attention, memory, motor performance, abstract conceptualization, and visuospatial perception. There were no significant differences between the groups on measures of socioeconomic status or education. Significant differences were found on three separate tests: WAIS-III Vocabulary, WAIS-III Similarities, and WMS-III Paired Associate Learning II. Although these tests measure distinct functions (vocabulary knowledge, abstract conceptualization, and delayed verbal recall), they may be influenced by broader verbal functions, such as verbal fluency, conceptualization, and the ability to articulate ideas. When patients were asked what functions had noticeably deteriorated since transplantation, nearly all complained of memory difficulties, and there was no difference between groups. However, more ALF than chronic liver disease (CLD) patients complained of concentration difficulties. The results of this study suggest that ALF patients may experience more neuropsychologic dysfunction after transplant. Further studies are required to expand on these initial observations with the potential to improve patient care and referral to appropriate rehabilitative services. [source] |